Grantham, Mayo, Van Otterloo & Co (GMO)’s BCE BCE Stock Holding History
Bought
Maintained
Sold
Other funds holding BCE
Grantham, Mayo, Van Otterloo & Co (GMO)'s BCE Position: Q4 2017 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of BCE (BCE) in Q4 2017, closing a stake of 4,800 shares — an estimated $225K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BCE in Q2 2013 and held it in 10 quarters. The position peaked at $86.8M in Q2 2016. 503 funds tracked by Wall St. Rank hold BCE as of Q4 2017.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining BCE position as of Q4 2017 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,800 BCE shares in Q4 2017, an estimated $225K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BCE in Q2 2013 and held it in 10 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s BCE position peaked at $86.8M in Q2 2016.
- 503 funds tracked by Wall St. Rank held BCE as of Q4 2017.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2017, filed 14 Feb 2018.